Work

Survival benefit with imatinib mesylate therapy in patients with accelerated‐phase chronic myelogenous leukemia—Comparison with historic experience

Year: 2005

Type: article

Source: Cancer

DOI: 10.1002/cncr.21032

Authors: Hagop Kantarjian, Moshe Talpaz, Susan O'Brien, Francis Giles, Stefan Faderl, Srdan Verstovsek, Guillermo Garcia‐Manero, Jianqin Shan, Mary Beth Rios, Richard Champlin, Marcos de Lima, Jorge Cortes

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2092509861

FWCI: 4.332

Cites: 32

Cited by: 71

Related to: 10